Multi-population genome-wide association meta-analysis of acute and chronic pancreatitis
- 1University of Pennsylvania Perelman School of Medicine
Abstract
Acute (AP) and chronic (CP) pancreatitis are major causes of gastrointestinal morbidity. However, the genetic architectures of AP and CP remain incompletely defined, as does the degree to which the two conditions share a common genetic basis. Here we report a multi-population GWAS meta-analysis of both AP and CP across five biobanks, comprising 23,292 individuals with and 1,748,420 individuals without AP across five populations and 9,866 individuals with and 1,627,720 individuals without CP across three populations. We identified 16 and 14 genome-wide significant loci for AP and CP, respectively. Combining nearest-gene assignment, fine-mapping, MAGMA, and colocalization with pancreatic eOTLs, we prioritized 7 genes for AP and 5 genes for CP using two or more approaches, including three previously unreported candidates: TM4SF4 and TCIM for AP, and FFAR4 for CP. We demonstrated that AP and CP are strongly correlated at the genome-wide level (rg=0.89); however, we identified 44 regions with significantly lower correlations, including a region on chromosome 18 containing BCL2 with a negative local correlation. Plasma proteome-wide Mendelian randomization (MR) found 15 proteins whose genetically predicted plasma levels were associated with AP and 6 associated with CP, including ABO, whose measured levels likely proxy non-O blood type. Consistent with this, we found that non-O blood type was modestly but significantly associated with both AP and CP in an analysis of electronic health records from over 650,000 individuals. Finally, drug-target MR identified 38 and 45 target genes whose genetically predicted expression levels were associated with genetic liability for AP and CP, respectively. Among these, DRD2 and BCHE (for AP and CP, respectively) were also supported by colocalization analysis. Overall, these results expand the known genetic architecture of pancreatitis and identify tractable therapeutic targets.
Related
- Association between frailty and multisite chronic pain in middle-aged and older adults: A population-based cross-sectional study with mediation analysis.
- A Genome-Wide Association Study in the Chilean admixed population reveals four new loci for COVID-19 severity and susceptibility
- The endocannabinoid signaling system in acute and chronic pancreatitis
- Endoscopic management of pancreatic duct stones and stricture in chronic pancreatitis using a fully covered self-expandable metal stent.
- Osteopathic manipulative treatment as an adjunct therapy in a pediatric patient with chronic pancreatitis and visceral hyperalgesia: a case report
BibTeX
@misc{khodursky2026multipopulation,
title = {{Multi-population genome-wide association meta-analysis of acute and chronic pancreatitis}},
author = {S. Khodursky and R. Judy and S. Abramowitz and M. G. Levin and S. M. Damrauer},
howpublished = {medRxiv},
year = {2026},
month = sep,
doi = {10.64898/2026.09.16.26363222},
url = {https://www.medrxiv.org/content/10.64898/2026.09.16.26363222v1},
note = {CC BY},
}
RIS
TY - UNPB
TI - Multi-population genome-wide association meta-analysis of acute and chronic pancreatitis
AU - S. Khodursky
AU - R. Judy
AU - S. Abramowitz
AU - M. G. Levin
AU - S. M. Damrauer
PY - 2026
DA - 2026/09/16
PB - medRxiv
DO - 10.64898/2026.09.16.26363222
UR - https://www.medrxiv.org/content/10.64898/2026.09.16.26363222v1
AB - Acute (AP) and chronic (CP) pancreatitis are major causes of gastrointestinal morbidity. However, the genetic architectures of AP and CP remain incompletely defined, as does the degree to which the two conditions share a common genetic basis. Here we report a multi-population GWAS meta-analysis of both AP and CP across five biobanks, comprising 23,292 individuals with and 1,748,420 individuals without AP across five populations and 9,866 individuals with and 1,627,720 individuals without CP across three populations. We identified 16 and 14 genome-wide significant loci for AP and CP, respectively. Combining nearest-gene assignment, fine-mapping, MAGMA, and colocalization with pancreatic eOTLs, we prioritized 7 genes for AP and 5 genes for CP using two or more approaches, including three previously unreported candidates: TM4SF4 and TCIM for AP, and FFAR4 for CP. We demonstrated that AP and CP are strongly correlated at the genome-wide level (rg=0.89); however, we identified 44 regions with significantly lower correlations, including a region on chromosome 18 containing BCL2 with a negative local correlation. Plasma proteome-wide Mendelian randomization (MR) found 15 proteins whose genetically predicted plasma levels were associated with AP and 6 associated with CP, including ABO, whose measured levels likely proxy non-O blood type. Consistent with this, we found that non-O blood type was modestly but significantly associated with both AP and CP in an analysis of electronic health records from over 650,000 individuals. Finally, drug-target MR identified 38 and 45 target genes whose genetically predicted expression levels were associated with genetic liability for AP and CP, respectively. Among these, DRD2 and BCHE (for AP and CP, respectively) were also supported by colocalization analysis. Overall, these results expand the known genetic architecture of pancreatitis and identify tractable therapeutic targets.
ER -